Quality improvement in travel medicine: A programme for yellow fever vaccination centres in England, Wales and Northern Ireland

Quality in Primary Care

Volumn 19, Issue 6, 2011, Pages 391-398

  Boddington, Nicola L ^a   Simons, Hilary ^a,b   Launders, Naomi ^c   Hill, David R ^a,d  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^c PUBLIC HEALTH ENGLAND   (United Kingdom)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Audit and feedback; General practice; Primary care; Quality improvement; Training; Vaccination; Yellow fever

Indexed keywords

YELLOW FEVER VACCINE;

ARTICLE; DRUG STORAGE; EMPORIATRICS; HUMAN; IN SERVICE TRAINING; ORGANIZATION AND MANAGEMENT; PRACTICE GUIDELINE; PREVENTIVE HEALTH SERVICE; PRIMARY HEALTH CARE; STANDARD; TOTAL QUALITY MANAGEMENT; UNITED KINGDOM;

DRUG STORAGE; GREAT BRITAIN; HUMANS; IMMUNIZATION PROGRAMS; INSERVICE TRAINING; PRACTICE GUIDELINES AS TOPIC; PRIMARY HEALTH CARE; QUALITY IMPROVEMENT; TRAVEL MEDICINE; YELLOW FEVER VACCINE;

EID: 84856618510     PISSN: 14791072     EISSN: 14791064     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Staples JE and Monath TP. Yellow fever: 100 years of discovery. Journal of the American Medical Association 2008;300(8):960-2.
2. Jentes ES, Poumerol G, Gershman MD et al for the Informal World Health Organization Working Group on Geographic Risk for Yellow Fever. The revised global yellow fever risk map and recommendations for vaccination, 2010: consensus of the Informal WHO Working Group on Geographic Risk for Yellow Fever. Lancet Infectious Diseases 2011; 11 (8) :622-32.
3. World Health Organization. International Health Regulations (2005). Geneva: World Health Organization, 2005:1-60. www.who.int/ihr/9789241596664/en/ index. html
4. Wilder-Smith A, Hill DR and Freedman DO. The revised International Health Regulation (2005): impact on yellow fever vaccination in clinical practice. American Journal of Tropical Medicine and Hygiene 2008;78(3): 359-60. (Pubitemid 351845178)
5. Field V, Ford L and Hill DR (eds). Health Information for Overseas Travel. London: National Travel Health Network and Centre, 2010.
6. Lindsey NP, Schroeder BA, Müller ER et al. Adverse event reports following yellow fever vaccination. Vaccine 2008; 26(48):6077-82.
7. Miravalle A, Biller J, Silva E, Conneely M and O'Keefe P. Acute disseminated encephalomyelitis: yellow fever vaccination. Arquivos Neuropsiquiatria 2009;67(3A):710-11.
8. Guimard T, Minjolle S, Polard E et al. Short report: incidence of yellow fever vaccine-associated neurotropic disease. American Journal of Tropical Medicine and Hygiene 2009;81 (6): 1141-3.
9. Staples JE, Gershman M and Fischer M. Yellow fever vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recommendations and Reports 2010;59(RR-7):1-27.
10. Thomas RE, Lorenzetti DL, Spragins W, Jackson D and Williamson T. Active and passive surveillance of yellow fever vaccine 17D or 17DD-associated serious adverse events: systematic review. Vaccine2011;29(28):4544-55.
11. Office of National Statistics, United Kingdom. Travel Trends 2009. Newport, UK: Office of Public Sector Information, 2010, pp. 1-131. www.statistics.gov.uk/downloads/theme-transport/travel-trends09.pdf
12. Bryant N, Tucker R, Simons H et al. Analysis of yellow fever vaccination practice in England. Journal of Travel Medicine 2008;15(5):287-93.
13. Centers for Disease Control and Prevention. Yellow Fever: the pre-travel consultation and best practices for yellow fever vaccination providers and clinics. Atlanta, GA: US Department of Health and Human Services, 2010. www.cdc.gov/tra vel-training/?s-cid-travelsite accessed November 2011.
14. Spira A. Yellow fever vaccine as a vehicle to better travel medicine. Journal of Travel Medicine 2005;12(6):303-5. (Pubitemid 43111733)
15. Labelle C and Macpherson DW. Evaluation of yellow fever vaccination centers in Canada. Journal of Travel Medicine 2005;12(4):180-3. (Pubitemid 41329374)
16. O'Brien B and Leggat PA. Linking yellow fever vaccinator approval and renewal with training in travel medicine in New Zealand. Travel Medicine and Infectious Diseases 2010;8(4):210-12.
17. Health Protection Agency. Act 2004. Chapter 17.22 July 2004. www.legislation.gov.uk/ukpga/2004/17/contents/ enacted (accessed 18 November 2011).
18. Welsh Assembly Government. Administration of yellow fever vaccination centres (YFVC), WHC 2005 (064).
19. July 2005. Cardiff, www.wales.nhs.uk/documents/WHC-2005-064.pdf
20. Chief Medical Officer. Designation and administration of yellow fever vaccination centres, HSS(MD) 21/2007.1 August 2007. Belfast, UK: Department of Health, Social Services and Public Safety, www.dhsspsni.gov.uk/hss-md-21-2007. pdf
21. Boddington NL, Simons H, Launders N et al. Evaluation of travel medicine practice by Yellow Fever Vaccination Centres in England, Wales, and Northern Ireland. Journal of Travel Medicine.
22. Worrall G, Chaulk P and Freake D. The effects of clinical practice guidelines on patient outcomes in primary care: a systematic review. Canadian Medical Association Journal 1997;156(12):1705-12. (Pubitemid 27283041)
23. Grol R and Grimshaw J. From best evidence to best practice: effective implementation of change in patients' care. The Lancet 2003;362(9391): 1225-30. (Pubitemid 37255352)
24. Leggat PA, Ross MH, Dürrheim DN, de Frey A and Blumberg LH. Linking yellow fever vaccination centre registration and training in travel medicine. Travel Medicine and Infectious Diseases 2003; 1:17-18. (Pubitemid 40432893)
25. Moerland W, Koeman SC, van den Hoek A et al. The quality of travel clinics in the Netherlands. Journal of Travel Medicine 2006;13(6):356-60. (Pubitemid 44722268)
26. Russell MN, Cetron MS and Barwick Eidex RB. The USCertified Yellow Fever Vaccination Center Registry: a tool for travelers, state health departments, and vaccine providers. Journal of Travel Medicine 2006;13(l):48-9.